AU592753B2 - Lymphokine in pure foem, novel monoclonal antibodies hybridoma cell lines, processes and applications - Google Patents
Lymphokine in pure foem, novel monoclonal antibodies hybridoma cell lines, processes and applicationsInfo
- Publication number
- AU592753B2 AU592753B2 AU42813/85A AU4281385A AU592753B2 AU 592753 B2 AU592753 B2 AU 592753B2 AU 42813/85 A AU42813/85 A AU 42813/85A AU 4281385 A AU4281385 A AU 4281385A AU 592753 B2 AU592753 B2 AU 592753B2
- Authority
- AU
- Australia
- Prior art keywords
- foem
- lymphokine
- pure
- applications
- processes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH255784 | 1984-05-24 | ||
CH2557/84 | 1984-05-24 | ||
CH378684 | 1984-08-07 | ||
CH3786/84 | 1984-08-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4281385A AU4281385A (en) | 1985-11-28 |
AU592753B2 true AU592753B2 (en) | 1990-01-25 |
Family
ID=25690762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU42813/85A Expired - Fee Related AU592753B2 (en) | 1984-05-24 | 1985-05-23 | Lymphokine in pure foem, novel monoclonal antibodies hybridoma cell lines, processes and applications |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU592753B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7084141B2 (en) | 2001-05-24 | 2006-08-01 | Avanir Pharmaceuticals | Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
US7173036B2 (en) | 2003-02-14 | 2007-02-06 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7361760B2 (en) | 2003-08-22 | 2008-04-22 | Avanir Pharmaceuticals | Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
US7365200B2 (en) | 2005-03-24 | 2008-04-29 | Avanir Pharmaceuticals | Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
-
1985
- 1985-05-23 AU AU42813/85A patent/AU592753B2/en not_active Expired - Fee Related
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7192961B2 (en) | 2001-05-24 | 2007-03-20 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7432374B2 (en) | 2001-05-24 | 2008-10-07 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7129236B2 (en) | 2001-05-24 | 2006-10-31 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7157469B2 (en) | 2001-05-24 | 2007-01-02 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7732146B2 (en) | 2001-05-24 | 2010-06-08 | Avanir Pharmaceuticals | Method for screening an agent that modulates activity of macrophage migration inhibitory factor |
US7192955B2 (en) | 2001-05-24 | 2007-03-20 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7105519B2 (en) | 2001-05-24 | 2006-09-12 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7202248B2 (en) | 2001-05-24 | 2007-04-10 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7084141B2 (en) | 2001-05-24 | 2006-08-01 | Avanir Pharmaceuticals | Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
US7235565B2 (en) | 2001-05-24 | 2007-06-26 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7230106B2 (en) | 2001-05-24 | 2007-06-12 | Avanir Pharmaceuticals | Process for the preparation of inhibitors of macrophage migration inhibitory factor |
US7238809B2 (en) | 2001-05-24 | 2007-07-03 | Avanir Pharmaceuticals | Process for the preparation of inhibitors of macrophage migration inhibitory factor |
US7514225B2 (en) | 2001-05-24 | 2009-04-07 | Avanir Pharmaceuticals | Method for screening an agent that modulates activity of macrophage migration inhibitory factor |
US7435737B2 (en) | 2001-05-24 | 2008-10-14 | Avanir Pharmaceutials | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7235546B2 (en) | 2003-02-14 | 2007-06-26 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7312220B2 (en) | 2003-02-14 | 2007-12-25 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7312221B2 (en) | 2003-02-14 | 2007-12-25 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7173036B2 (en) | 2003-02-14 | 2007-02-06 | Avanir Pharmaceuticals | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
US7361760B2 (en) | 2003-08-22 | 2008-04-22 | Avanir Pharmaceuticals | Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
US7365200B2 (en) | 2005-03-24 | 2008-04-29 | Avanir Pharmaceuticals | Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
Also Published As
Publication number | Publication date |
---|---|
AU4281385A (en) | 1985-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0205405A3 (en) | Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications | |
AU555575B2 (en) | Polypeptide preparation in vertebrate cell culture | |
AU4154385A (en) | Antibodies, manufacture and use | |
IL79719A (en) | Pharmaceutical composition comprising monoclonal antibodies binding determinants of gram negative bacteria and hybridoma cell lines producing the antibodies | |
DE3377363D1 (en) | Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells | |
IL67721A (en) | Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies | |
IL70573A0 (en) | Cell lines,their production and their use for producing proteins | |
IL88160A0 (en) | Cell lines and monoclonal antibodies | |
AU616156B2 (en) | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections | |
EP0174204A3 (en) | Gram-negative bacterial endotoxin blocking monoclonal antibodies and cells producing the same and formulations containing the same, and the production of all thereof | |
AU6373286A (en) | Auto-anti-idiotypic monoclonal antibodies to steroid receptals and uses thereof | |
AU580755B2 (en) | Cryogenic cell | |
GB2153364B (en) | Lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses | |
EP0114670A3 (en) | Novel cell lines for use in the preparation of hybridoma cells | |
AU7784187A (en) | Monoclonal antibody against ovarian cancer cells (ovb-3) | |
AU592753B2 (en) | Lymphokine in pure foem, novel monoclonal antibodies hybridoma cell lines, processes and applications | |
AU4970885A (en) | Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses | |
AU7913887A (en) | Method for the removal of undesired cells from human lymphocyte populations, application of the method in monoclonal antibody production and kit therefor | |
AU4070685A (en) | Monoclonal antibody specific for human basal cell surfaces | |
DE3561242D1 (en) | Peroxycarbonate group-containing copolymer and method for manufacture thereof | |
ZA853915B (en) | Lymphokine in pure form,novel monoclonal antibodies,hybridoma cell lines,processes and applications | |
AU582416B2 (en) | Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms | |
AU4174789A (en) | Hybrid monoclonal antibodies, their production and use | |
AU3617984A (en) | Cell line and monoclonal antibody | |
IL86678A0 (en) | Hybrid cell line and monoclonal antibodies |